Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Arya Sciences Acquisition Corp II (ARYBU)

Arya Sciences Acquisition Corp II (ARYBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Cerevel Therapeutics Debuts as Publicly Traded Neuroscience Company Globe NewsWire - Wed Oct 28, 2020

B usiness combination transaction with Arya Sciences Acquisition Corp II, a special purpose acquisition company sponsored by Perceptive Advisors, completed on October 27, 2020

ARYBU : 10.39 (-1.05%)
ARYA Sciences Acquisition Corp II Announces Extraordinary General Meeting Teleconference Details Globe NewsWire - Wed Oct 21, 2020

NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp II (“ ARYA ”) (Nasdaq: ARYB), today announced that, due to the public health and safety concerns related to the coronavirus...

ARYBU : 10.39 (-1.05%)
ARYBW : 1.8300 (+7.02%)
ARYB : 10.10 (+0.90%)
Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development Business Wire - Thu Jul 30, 2020

Cerevel Therapeutics, Inc. (“Cerevel Therapeutics”) , a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Arya Sciences Acquisition Corp II (Nasdaq: ARYBU)...

ARYBU : 10.39 (-1.05%)
ARYA Sciences Acquisition Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 24, 2020 Globe NewsWire - Wed Jul 22, 2020

New York, New York, July 22, 2020 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp II (Nasdaq: ARYBU) (the “Company”) announced today that, commencing July 24, 2020, holders of the units sold in...

ARYBU : 10.39 (-1.05%)
ARYA Sciences Acquisition Corp. Announces Annual General Meeting Teleconference Details Globe NewsWire - Mon Jun 22, 2020

New York, NY, June 22, 2020 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp. (“ARYA” or “the Company”) (NASDAQ: ARYA), today announced that, due to the public health and safety concerns...

ARYBU : 10.39 (-1.05%)
ARYA : 11.16 (+4.49%)

Barchart Exclusives

Stock Index Futures Climb as Fed Rate Cut Hopes Grow, Fed Speak and ECB Minutes in Focus Barchart - 57 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.40%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.44% this morning after three major U.S. benchmark indices ended the regular session in the green as higher-than-expected applications for U.S. unemployment benefits bolstered the case for rate cuts, with investors looking ahead to fresh comments from Federal Reserve officials. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot